Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bayamon, PR
NPI
1376505586
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
Tt14 Calle 37, Santa Juanita
Bayamon, PR, 00956
Phone (787) 787-0933
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
217 services
Medicare patients, 2024
58
Average age 77
Drug cost, 2024
$3.8M
25,759 prescriptions
Company payments, 2025
$646
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Altagracia A Alcantara Gonzalez was code 99213 (office e&m - established), 131 times for 55 patients. In total Altagracia A Alcantara Gonzalez billed 217 services in 6 codes, and Medicare paid $11K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-17.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 131 | 55 | $66.19 | $8,671 |
| 99211 Office E&M - Established | Office | 73 | 33 | $18.05 | $1,318 |
By year: 2022 $12K for 245 services; 2023 $12K for 230 services; 2024 $11K for 217 services.
Medicare prescription drug claims, 2024
In 2024, the drug Altagracia A Alcantara Gonzalez prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 3,604 prescriptions and refills. In total Altagracia A Alcantara Gonzalez wrote 25,759 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 3,604 | 5,073 | 537 | $224K |
| Atorvastatin Calcium Generic | 1,157 | 1,730 | 240 | $9,186 |
| Gabapentin Generic | 1,032 | 1,339 | 205 | $9,602 |
| Levothyroxine Sodium Generic | 897 | 1,376 | 166 | $9,842 |
| Rosuvastatin Calcium Generic | 861 | 1,304 | 192 | $8,601 |
| Farxiga Dapagliflozin Propanediol | 753 | 909 | 127 | $528K |
| Metformin Hcl Generic | 724 | 1,065 | 135 | $3,963 |
| Losartan Potassium Generic | 692 | 1,020 | 137 | $5,653 |
| Omega-3 Acid Ethyl Esters Generic | 538 | 699 | 109 | $31K |
| Famotidine Generic | 535 | 683 | 117 | $4,190 |
| Metoprolol Succinate Generic | 500 | 780 | 101 | $6,635 |
| Simvastatin Generic | 472 | 688 | 102 | $2,811 |
| Ozempic Semaglutide | 461 | 476 | 64 | $463K |
| Alendronate Sodium Generic | 447 | 620 | 92 | $3,406 |
| Metformin Hcl Er Metformin Hcl | 432 | 679 | 82 | $3,104 |
Brand drugs: 9,098 claims; generic drugs: 16,420 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Altagracia A Alcantara Gonzalez $646 ($646 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $168.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.